TRAF-dependent association of protein kinase Tpl2/COT1 (MAP3K8) with CD40

Biochemical and Biophysical Research Communications

Volumn 328, Issue 1, 2005, Pages 198-205

  Chan, Henry ^a   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

CD40; COT1; MAP3K8; Tpl2; TRAF

Indexed keywords

ADAPTOR PROTEIN; CD40 ANTIGEN; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MIXED LINEAGE KINASE; MIXED LINEAGE KINASE 8; PROTEIN KINASE; PROTEIN KINASE COT1; PROTEIN KINASE TPL2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CATALYSIS; ENZYME ACTIVATION; ENZYME INDUCTION; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIGENS, CD40; CELL LINE; HUMANS; KIDNEY; MAP KINASE KINASE KINASES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12844276629     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.12.155     Document Type: Article

References (28)

1. R.J. Noelle CD40 and its ligand in host defense Immunity 4 1996 415 419
2. C. van Kooten, and J. Banchereau CD40-CD40 ligand J. Leukoc. Biol. 67 2000 2 17
3. V. Henn, J.R. Slupsky, M. Grafe, I. Anagnostopoulos, R. Forster, G.M. Berghaus, and R.A. Kroczek CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells Nature 391 1998 591 594
4. U. Schonbeck, G.K. Sukhova, K. Shimizu, F. Mach, and P. Libby Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice Proc. Natl. Acad. Sci. USA 97 2000 7458 7463
5. C. Dong, R.J. Davis, and R.A. Flavell MAP kinases in the immune response Annu. Rev. Immunol. 20 2002 55 72
6. Y. Kosaka, D.M. Calderhead, E.M. Manning, J.E. Hambor, A. Black, R. Geleziunas, K.B. Marcu, and R.J. Noelle Activation and regulation of the IkappaB kinase in human B cells by CD40 signaling Eur. J. Immunol. 29 1999 1353 1362
7. J.M. Zapata TNF-receptor-associated factors as targets for drug development Expert Opin. Ther. Targets 7 2003 411 425
8. H. Wajant, F. Henkler, and P. Scheurich The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators Cell Signal. 13 2001 389 400
9. J. Miyoshi, T. Higashi, H. Mukai, T. Ohuchi, and T. Kakunaga Structure and transforming potential of the human cot oncogene encoding a putative protein kinase Mol. Cell. Biol. 11 1991 4088 4096
10. C. Patriotis, A. Makris, S.E. Bear, and P.N. Tsichlis Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation Proc. Natl. Acad. Sci. USA 90 1993 2251 2255
11. A.G. Eliopoulos, C. Davies, S.S. Blake, P. Murray, S. Najafipour, P.N. Tsichlis, and L.S. Young The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2 J. Virol. 76 2002 4567 4579
12. A.G. Eliopoulos, C.C. Wang, C.D. Dumitru, and P.N. Tsichlis Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40 EMBO J. 22 2003 3855 3864
13. C. Patriotis, A. Makris, J. Chernoff, and P.N. Tsichlis Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase Proc. Natl. Acad. Sci. USA 91 1994 9755 9759
14. A. Salmeron, T.B. Ahmad, G.W. Carlile, D. Pappin, R.P. Narsimhan, and S.C. Ley Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase EMBO J. 15 1996 817 826
15. C. Tsatsanis, C. Patriotis, S.E. Bear, and P.N. Tsichlis The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines Proc. Natl. Acad. Sci. USA 95 1998 3827 3832
16. M.P. Belich, A. Salmeron, L.H. Johnston, and S.C. Ley TPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB p105 Nature 397 1999 363 368
17. X. Lin, T. Emmett, J. Cunninghman, Y. Mu, R. Geleziunas, and W.C. Greene The proto-oncogene Cot kinase participates in the CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases Immunity 10 1999 271 280
18. C.D. Dumitru, J.D. Ceci, C. Tsatsanis, D. Kontoyiannis, K. Stamatakis, J.-H. Lin, C. Patriotis, N.A. Jenkins, N.G. Copeland, G. Kollias, and P.N. Tsichlis TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway Cell 103 2000 1071 1083
19. E. Leo, K. Welsh, S. Matsuzawa, J.M. Zapata, S. Kitada, R. Mitchell, K.R. Ely, and J.C. Reed Differential requirements for TRAF-family proteins in CD40-mediated induction of NF-κB and JNK activation J. Biol. Chem. 274 1999 22414 22474
20. C. Patriotis, M.G. Russeva, J.H. Lin, S.M. Srinivasula, D.Z. Markova, C. Tsatsanis, A. Makris, E.S. Alnemri, and P.N. Tsichlis Tpl-2 induces apoptosis by promoting the assembly of protein complexes that contain caspase-9, the adapter protein Tvl-1, and procaspase-3 J. Cell. Physiol. 187 2001 176 187
21. S.-Y. Hong, W.-H. Yoon, J.-H. Park, S.-G. Kang, J.-H. Ahn, and T.H. Lee Involvement of two NF-kB binding elements in tumor necrosis factor a-, CD40-, and Epstein-Barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene J. Biol. Chem. 275 2000 18022 18028
22. T.W. Mak, and W.C. Yeh Signaling for survival and apoptosis in the immune system Arthritis Res. 4 3 2002 S243 252
23. J. Ninomiya-Tsuji, K. Kishimoto, A. Hiyama, J. Inoue, Z. Cao, and K. Matsumoto The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway Nature 398 1999 252 256
24. J. Lee, L. Mira-Arbibe, and R.J. Ulevitch TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide J. Leukoc. Biol. 68 2000 909 915
25. J. Mizukami, G. Takaesu, H. Akatsuka, H. Sakurai, J. Ninomiya-Tsuji, K. Matsumoto, and N. Sakurai Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6 Mol. Cell. Biol. 22 2002 992 1000
26. G. Takaesu, S. Kishida, A. Hiyama, K. Yamaguchi, H. Shibuya, K. Irie, J. Ninomiya-Tsuji, and K. Matsumoto TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway Mol. Cell 5 2000 649 658
27. L.P. Kane, M.N. Mollenauer, Z. Xu, C.W. Turck, and A. Weiss Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription Mol. Cell. Biol. 22 2002 5962 5974
28. J.Y. Chung, Y.C. Park, H. Ye, and H. Wu All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction J. Cell Sci. 115 2002 679 688